Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses

Nature Communications

Volumn 7, Issue , 2016, Pages

  Holm, Christian K ^a   Rahbek, Stine H ^a   Gad, Hans Henrik ^a   Bak, Rasmus O ^a   Jakobsen, Martin R ^a   Jiang, Zhaozaho ^b   Hansen, Anne Louise ^a   Jensen, Simon K ^a   Sun, Chenglong ^a   Thomsen, Martin K ^a   Laustsen, Anders ^a   Nielsen, Camilla G ^a   Severinsen, Kasper ^c   Xiong, Yingluo ^a,d   Burdette, Dara L ^e   Hornung, Veit ^f   Lebbink, Robert Jan ^g   Duch, Mogens ^a,h   Fitzgerald, Katherine A ^b   Bahrami, Shervin ^a,h   Mikkelsen, Jakob Giehm ^a   Hartmann, Rune ^a   Paludan, Søren R ^a   more..

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d FUDAN UNIVERSITY   (China)

^e University of California Berkeley   (United States)

^f UNIVERSITY HOSPITAL BONN   (Germany)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h Skauvaccines ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CGAMP SYNTHASE; CYCLIC AMP; CYCLIC GMP; EARLY ENDOSOME ANTIGEN 1; HEMAGGLUTININ; NONSTRUCTURAL PROTEIN 1; PROTEIN; STIMULATOR OF INTERFERON GENES PROTEIN; SYNTHETASE; UNCLASSIFIED DRUG; VIRUS RNA; INTERFERON; MB21D1 PROTEIN, HUMAN; MB21D1 PROTEIN, MOUSE; MEMBRANE PROTEIN; MPYS PROTEIN, HUMAN; MPYS PROTEIN, MOUSE; NUCLEOTIDYLTRANSFERASE;

DNA; GENE; INFLUENZA; MEMBRANE; PEPTIDE; RNA; VIRUS;

ANIMAL CELL; ARTICLE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONTROLLED STUDY; DIMERIZATION; HUMAN; INFLUENZA A VIRUS; INNATE IMMUNITY; INTERFERON PRODUCTION; LIPID MEMBRANE; MEMBRANE FUSION; MOUSE; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; RNA VIRUS; WESTERN BLOTTING; ANIMAL; ENZYMOLOGY; GENETICS; INFLUENZA; METABOLISM; PHYSIOLOGY; RNA VIRUS INFECTION; VIROLOGY;

DNA VIRUSES; INFLUENZA A VIRUS; RNA VIRUSES;

ANIMALS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INTERFERON TYPE I; MEMBRANE PROTEINS; MICE; NUCLEOTIDYLTRANSFERASES; RNA VIRUS INFECTIONS; RNA VIRUSES;

EID: 84959036465     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10680     Document Type: Article

References (34)

1. Medzhitov, R. Origin and physiological roles of inflammation. Nature 454, 428-435 (2008).
2. Takeuchi, O., Akira, S. Innate immunity to virus infection. Immunol. Rev. 227, 75-86 (2009).
3. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730-737 (2004).
4. Ouyang, S. et al. Structural analysis of the STING adaptor protein reveals a hydrophobic dimer interface and mode of cyclic di-GMP binding. Immunity 36, 1073-1086 (2012).
5. Ishikawa, H., Ma, Z., Barber, G. N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788-792 (2009).
6. Gao, P. et al. Structure-function analysis of STING activation by c[G(20,50)pA(30,50)p] and targeting by antiviral DMXAA. Cell 154, 748-762 (2013).
7. Zhang, X. et al. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol. Cell 51, 226-235 (2013).
8. Tanaka, Y., Chen, Z. J. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci. Signal. 5, ra20 (2012).
9. Ishikawa, H., Barber, G. N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674-678 (2008).
10. Aguirre, S. et al. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog. 8, e1002934 (2012).
11. Sun, L. et al. Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling. PLoS ONE 7, e30802 (2012).
12. Ding, Q. et al. Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity. J. Hepatol. 59, 52-58 (2013).
13. Goubau, D., Deddouche, S., Reis e Sousa, C. Cytosolic sensing of viruses. Immunity 38, 855-869 (2013).
14. Holm, C. K. et al. Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING. Nat. Immunol. 13, 737-743 (2012).
15. Liu, Y. P. et al. Endoplasmic reticulum stress regulates the innate immunity critical transcription factor IRF3. J. Immunol. 189, 4630-4639 (2012).
16. Bowie, A. G., Unterholzner, L. Viral evasion and subversion of patternrecognition receptor signalling. Nat. Rev. Immunol. 8, 911-922 (2008).
17. Gack, M. U. et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell. Host. Microbe. 5, 439-449 (2009).
18. Han, X., Bushweller, J. H., Cafiso, D. S., Tamm, L. K. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nat. Struct. Biol. 8, 715-720 (2001).
19. Wilson, I. A., Skehel, J. J., Wiley, D. C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3A resolution. Nature 289, 366-373 (1981).
20. Bahrami, S., Laska, M. J., Pedersen, F. S., Duch, M. Immune suppressive activity of the influenza fusion peptide. Virus Res. 211, 126-132 (2015).
21. Jin, L. et al. MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic-di-GMP. J. Immunol. 187, 2595-2601 (2011).
22. Burdette, D. L. et al. STING is a direct innate immune sensor of cyclic di-GMP. Nature 478, 515-518 (2011).
23. Huang, Y. H., Liu, X. Y., Du, X. X., Jiang, Z. F., Su, X. D. The structural basis for the sensing and binding of cyclic di-GMP by STING. Nat. Struct. Mol. Biol. 19, 728-730 (2012).
24. Paludan, S. R., Bowie, A. G. Immune sensing of DNA. Immunity 38, 870-880 (2013).
25. Bhoj, V. G. et al. MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus. Proc. Natl Acad. Sci. USA 105, 14046-14051 (2008).
26. Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101-105 (2006).
27. Rasmussen, S. B. et al. Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems. J. Virol. 81, 13315-13324 (2007).
28. Liu, Y. et al. Activated STING in a vascular and pulmonary syndrome. N. Engl. J. Med. 371, 507-518 (2014).
29. Park, M. S. et al. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V,W, and C proteins. J. Virol. 77, 1501-1511 (2003).
30. van de Weijer, M. L. et al. A high-coverage shRNA screen identifies TMEM129 as an E3 ligase involved in ER-associated protein degradation. Nat. Commun. 5, 3832 (2014).
31. Mankan, A. K. et al. Cytosolic RNA:DNA hybrids activate the cGAS-STING axis. EMBO J. 33, 2937-2946 (2014).
32. Bak, R. O., Hollensen, A. K., Primo, M. N., Sorensen, C. D., Mikkelsen, J. G. Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors. RNA 19, 280-293 (2013).
33. Torralba, S., Sojat, J., Hartmann, R. 20-50 oligoadenylate synthetase shares active site architecture with the archaeal CCA-adding enzyme. Cell. Mol. Life Sci. 65, 2613-2620 (2008).
34. Ank, N., Petersen, K., Malmgaard, L., Mogensen, S. C., Paludan, S. R. Age-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2. J. Virol. 79, 9831-9841 (2005).